Zongrui Xing

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Signaling Pathway

Top Venues

Current cancer drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Zongrui Xing, Xiangyan Jiang, Yuxia Wu, Zeyuan Yu
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy. Current cancer drug targets 24 (9) (2024)
Zongrui Xing, Xiangyan Jiang, Yuxia Wu, Zeyuan Yu
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy. Current cancer drug targets (2024)